期刊文献+

非小细胞肺癌中CD147和MMP2的表达及意义 被引量:8

Expressions of CD 147 and MMP2 in None Small Cell Lung Cancer and its Significance
下载PDF
导出
摘要 目的探讨CD147和MMP2在非小细胞肺癌(NSCLC)中的表达及意义。方法应用免疫组织化学方法 SP法检测80例NSCLC及20例癌旁组织中CD147和MMP2的表达情况。结果 CD147和MMP2在20例癌旁组织中阳性表达率分别为20%、15%;CD147、MMP2在NSCLC中的阳性表达率分别为66.3%、70.0%(P均<0.01)。CD147和MMP2的表达均与NSCLC患者的临床分期及淋巴结转移相关(P均<0.05),与组织学分型及肿瘤分化程度无关(P均﹥0.05)。结论 CD147和MMP2在NSCLC中高表达,两者在NSCLC的发生发展中可能发挥着重要作用。 Objective To investigate expressions of CD147 and MMP2 in none small cell lung caner and its significance. Method The expressions of CD 147 and MMP2 in 80 cases with none small cell lung caner and 20 cases with paraneoplastic of the none small cell lung caner were detected by immunohistoehemical SP method. Results In 20 specimens with paraneoplastic of the none small cell lung ca- ner, the expressions of CD147 and MMP2 were 20% and 15% (all P 〈0. 01 ) , The expressions of CD147 and MMP2 in none small cell lung caner were 66. 3% and 70. 0% ( all P 〈0. 05). The expressions of CD147 and MMP2 in none small cell lung cancer were related to clinical stage and lymph node metastases and not related to tumor histological type and tumor differentiation. Expression of CD147 was pos- itively correlated to MMP2 (r =0. 738). Conclusion CD147 and MMP2 expressions were high in none small cell lung caner, and they play important roles in carcinogenesis of none small cell lung caner.
作者 王莉 高爱平
机构地区 安徽省胸科医院
出处 《临床肺科杂志》 2012年第12期2237-2238,共2页 Journal of Clinical Pulmonary Medicine
关键词 肺癌 免疫组化 CD147 MMP2 NSCLC Immunohistochemical CD147 MMP2
  • 相关文献

参考文献8

  • 1Guo H, Li R, Zucker S, et al. EMMPRIN ( CD147 ), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenasc to the tumor cell surface [ J ]. Cancer Res,2000,60 (4) : 888 - 891.
  • 2Nabeshima K, Iwasaki H, Koga K, et al. Emmprin (basigin / CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression [J]. Pathol Int, 2006, 56(7) : 359 -67.
  • 3Sameshma T, Nabeshima K, Toole BP, et al. Expression of emmprin ( CD147 ), a cell surface inducer of matrix metalloproteinases in normal human brain and gliomas [ J]. Int J Cancer, 2000, 88 (1): 21 -27.
  • 4Tang Y,Nakada MT, Kesavan P, et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases [ J ]. Cancer Res,2005,65 ( 8 ) :3193 - 3199.
  • 5Liang YX,He HC,Han ZD,et al. cD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value[ J]. cancer Invest ,2009,27 ( 7 ) :788 - 793.
  • 6Yan L,Zucker S,Toole BP. Roles of the multitunctional glycoprotein, emmprin ( basigin, CD147 ), in tumour progression [ J ]. Thromb Haemost ,2005,93 ( 2 ) : 199 - 204.
  • 7Gerhards S,lung K, Koenig F, et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma [ J ]. Urology, 2001,57 ( 4 ) : 675 - 679.
  • 8Sier CF, Casetta G, Verheijen JH, et al. Enhanced urinary gelatinase activities( matrix metalloproteinases 2 and 9 ) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers [ J ]. Clin Cancer Res,2000,6 ( 6 ) :2333 - 2340.

同被引文献88

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部